PRICE MICHAEL DENNIS
Insider CIK 1247313 · AKCA Chief Financial Officer · NVLN Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKCA AKCEA THERAPEUTICS, INC. | D To issuer deriv | 2020-10-12 | 2020-10-13 | 300,000 | $3.37 | $1.01M | 0 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | U Tender | 2020-10-12 | 2020-10-13 | 50,000 | $18.15 | $907.5K | 0 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | A Award deriv | 2020-05-18 | 2020-05-19 | 300,000 | — | $0 | 300,000 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | A Award | 2020-05-18 | 2020-05-19 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | F Tax w/h | 2019-09-24 | 2019-09-26 | 3,926 | $0.76 | $3.0K | 14,111 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | F Tax w/h | 2018-11-27 | 2018-11-28 | 1,963 | $0.92 | $1.8K | 18,037 | SEC↗ |